Adults ages 18 & up and living with chronic kidney disease needed for a research trial.
- Start date
- Multiple start dates
- Therapy area(s)
- Liver & kidney health
- Location
- 13 clinics
- Compensation
- Compensation for your participation may be available
- Status
-
Enrolling now
Requirements
Participants must meet the following criteria:
- 18 – 65
- Non-Diabetic
- Diagnosis of Chronic Kidney Disease (CKD) or eGFR between 25 – 75 (if known)
- Health status is further evaluated by reviewing medical history, screening assessments, and visit with physician
- Available and willing to commit to study visit structure
About study
The purpose of the study is to test for APOL1 risk variants and, for qualifying patients, investigate a medication designed to improve kidney function by targeting the root cause of AMKD. By participating, you can play a vital role in advancing research and paving the way for potential new treatment options that address the underlying cause of this historically untreated condition.
Submit request for call back.
You can sign up by calling the clinic’s call center or request a call back here.
Locations
Location | Start date | Status |
---|---|---|
Atlanta |
Register interest now
|
|
Austin |
Register interest now
|
|
Birmingham |
Register interest now
|
|
Chicago |
Register interest now
|
|
Evansville |
Register interest now
|
|
Huntsville |
Register interest now
|
|
Las Vegas |
Register interest now
|
|
Melbourne |
Register interest now
|
|
Minneapolis |
Register interest now
|
|
Phoenix |
Register interest now
|
|
San Antonio |
Register interest now
|
|
The Villages |
Register interest now
|
|
Tucson |
Register interest now
|